Novo Nordisk A/S News Headlines

NVO 
$44.16
*  
0.01
 negative 
0.02%
Get NVO Alerts
*Delayed - data as of Apr. 21, 2014 12:21 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
4/16/2014 8:07:00 AM - Seeking Alpha

Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
4/15/2014 5:25:01 PM - Zacks.com

Encouraging Results from Lexicon Candidate - Analyst Blog
4/15/2014 5:20:01 PM - Zacks.com

Glaxo Wins U.S. Approval for Diabetes Drug
4/15/2014 2:25:00 PM - Dow Jones Business News

Glaxo Wins U.S. Approval for Diabetes Treatment Albiglutide
4/15/2014 2:13:00 PM - Dow Jones Business News

Novo Nordisk Seeks to Boost Sales of Insulin in U.S., Mexico
4/14/2014 11:39:00 AM - Dow Jones Business News

MannKind Slips on Afrezza Approval Delay - Analyst Blog
4/8/2014 8:52:01 AM - Zacks.com

Is It Too Early To Invest In Versartis?
4/2/2014 9:08:00 AM - Seeking Alpha

MannKind's Inhaled Insulin One Step Away From Approval...
4/2/2014 5:33:00 AM - RTT News

MannKind Down on FDA's Briefing Document - Analyst Blog
3/31/2014 4:45:01 PM - Zacks.com

Glaxo's Eperzan Approved in EU - Analyst Blog
3/27/2014 7:00:01 PM - Zacks.com

Positive CHMP Opinion for Novo Nordisk's Drugs - Analyst Blog
3/25/2014 4:30:01 PM - Zacks.com

Novo Nordisk Upgraded to 'Buy'
3/24/2014 11:43:00 AM - Fox Business

Positive Data on Novo Nordisk's N8-GP - Analyst Blog
3/20/2014 12:50:01 PM - Zacks.com

Novo Nordisk Extends Diabetes Operations - Analyst Blog
3/19/2014 4:50:01 PM - Zacks.com

Novo Nordisk: First Phase 3 Trial With N8-GP Shows Positive Results
3/19/2014 8:54:00 AM - RTT News

Eli Lilly - The 'Never Say Die' Pharmaceutical
3/11/2014 3:35:00 PM - Seeking Alpha

New Diagnostic Test From Roche - Analyst Blog
3/11/2014 11:30:01 AM - Zacks.com

Positive Data on Novartis' Jakavi - Analyst Blog
3/10/2014 4:50:01 PM - Zacks.com

Label Expansion for Novartis' Xolair - Analyst Blog
3/7/2014 6:30:01 PM - Zacks.com

Encouraging Data from Roche - Analyst Blog
3/6/2014 5:35:01 PM - Zacks.com

Regulatory Setback for Eli Lilly - Analyst Blog
3/6/2014 1:00:01 PM - Zacks.com

Novo Nordisk (NVO) Enters Oversold Territory - Tale of the Tape
3/6/2014 10:24:01 AM - Zacks.com

Promising Data on Merck Allergy Drug - Analyst Blog
3/5/2014 6:50:01 PM - Zacks.com

Update on Bayer/Regeneron's Eylea - Analyst Blog
3/5/2014 5:55:01 PM - Zacks.com